Welcome to the Gleason Lab!
Mission
Our mission is to ensure that Alzheimer’s disease and related dementias research benefits everyone. We are committed to addressing the disease as a public health priority and to engaging populations most affected by the disease yet under-included in research. By prioritizing representation across differences in culture, geography, education, co-existing health conditions, and lived experience, we aim to produce research that reflects the true breadth of the population, leading to more comprehensive and impactful scientific outcomes. We believe partnership with communities is essential for groundbreaking discoveries.
Vision
We envision a future where Alzheimer’s disease and related dementias research is truly representative of all individuals, and where the unique experiences and needs of every person within our communities are integrated into the science.
Values
At our research unit, we are guided by a deep commitment to:
- Fairness: We prioritize fairness by ensuring that all individuals, regardless of background, have an opportunity to participate in and benefit from Alzheimer’s research.
- Representation: We actively seek to include a broad range of people in our studies, recognizing that doing so makes our science stronger, and discoveries more meaningful for all.
- Trust: We are dedicated to building trust with communities we serve by engaging with them respectfully, transparently, and consistently throughout the research process.
- Collaboration: We believe that the best solutions emerge when we work together—across disciplines, communities, and perspectives—to create research that truly reflects the needs of all people.
- Integrity: We uphold the highest ethical standards in our research, ensuring that the voices of those affected by Alzheimer’s disease are heard and their needs are met with integrity and care.
- Innovation: We strive to push the boundaries of science by embracing new methods, perspectives, and ideas to address the complex challenges of Alzheimer’s disease.
News from the Gleason Lab
Thank you, Dr. Carter, for all you do!
We congratulate Dr. Fabu Carter on her 10 years of service to the Alzheimer’s Disease Research Program (ADRC and WRAP together). Her dedication to the work of inclusion has transformed our collective research endeavor. Thank …
January 14, 2025Research Visits at UW South Madison Partnership Office
The ADRC is now offering the UW South Madison Partner Office as an option for study visits outside of the hospital setting, located in the Community Data Collection Project Site at the office in room …
January 14, 2025Healthy Living with Mild Cognitive Impairment (MCI) Education Series
Healthy Living with Mild Cognitive Impairment is an educational series that provides individuals with MCI and their care partners with guidance through science based strategies. These strategies empower participants with knowledge they can apply to …
January 14, 2025Dr. Gilda Ennis presents at 2024 CTAD Conference
Dr. Gilda Ennis, PhD, Gleason Lab Scientist gave an oral presentation on research describing the performance of blood-based p-tau217, a biomarker of Alzheimer’s disease (AD), in Black Americans enrolled in the African Americans Fighting Alzheimer’s …
November 1, 2024Wisconsin ADRC hosts drive thru event with free resources and vaccine clinic
Almost 250 people attended a drive-thru resource fair in Madison’s Penn Park on July 31. The event, hosted by the Wisconsin Alzheimer’s Disease Research Center, featured over 15 organizations with info on healthy aging, a free …
August 11, 2021- Read more news
How to Join a Research Lab
If you are a trainee looking for information about joining a lab, visit the Wisconsin Alzheimer's Disease Research Center's How to Join a Research Lab page.
